Correction to: Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis

The original version of this article unfortunately contained a mistake.There are 2 data errors in the results section of the abstract.In abstract, first sentence of the results section should read as As of January 31, 2022, 307 patients were enrolled from 14 countries.Mean (standard deviation [SD]) ages at first symptoms and at genetic diagnosis were 2.9 (1.7) years and 5.4 (3.1) years, respectively.Mean (SD) duration of ataluren exposure was 1671 (566.8)days.